Athyrium Opportunities III Co-Invest 1 LP
SEC insider (Form 3/4/5 filer). CIK 0001815260. Director & 10% Owner at BIORA THERAPEUTICS, INC. (BIOR). 1 reported Form 4/5 transaction since Sep 2024; latest on Dec 12, 2024. Located in NEW YORK, NY.
Companies Athyrium Opportunities III Co-Invest 1 LP has filed insider reports for
- BIORA THERAPEUTICS, INC. (BIOR): Director, 10% Owner
Athyrium Opportunities III Co-Invest 1 LP
CIK: 0001815260
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BIOR
BIORA THERAPEUTICS, INC.
Director10% Owner
Discretionary Trading P&L
Holdings
Transaction History (1 total)
- Dec 12, 2024BIOR
BIORA THERAPEUTICS, INC.
AwardIndirect11.00% / 13.00% Convertible Senior Secured Notes due 2028
0 shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Dec 12, 2024 | BIOR BIORA THERAPEUTICS, INC. | Award 11.00% / 13.00% Convertible Senior Secured Notes due 2028 | 0 | - | - | Indirect |
1-1 of 1 transactions